937593-03-8Relevant articles and documents
Design and synthesis of cyclic acylguanidines as BACE1 inhibitors
Liu, Jia-Kuo,Gu, Wei,Cheng, Xiao-Rui,Cheng, Jun-Ping,Zhou, Wen-Xia,Nie, Ai-Hua
supporting information, p. 1327 - 1330 (2015/12/31)
Based on the lead compound 1 reported in literature, a series of novel BACE1 inhibitors were designed and synthesized, among which compound 11 exhibited a 14-fold improvement in potency over the lead compound 1. This represents a good lead for the discovery of more promising BACE1 inhibitors for the potential treatment of AD.
NEW COMPOUNDS
-
Page/Page column 165, (2008/06/13)
This invention relates to novel compounds having the structural formula I below: and to their pharmaceutically acceptable salt, compositions and methods of use. These novel compounds provide a treatment or prophylaxis of cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.